Ptosis

Oxymetazoline hydrochloride has been recognized by the publication as a winner of its Best of Beauty Breakthrough Award.

The development of involutional ptosis may be a multifactorial process, researchers have found.

New data finds that preoperative ptosis occurs commonly and more often in patients with reactive blepharospasm or enophthalmos.

Researchers consider frequency and factors in etiology of complication

Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) has the potential to treat patients with varying degrees of severity of acquired ptosis compared with vehicle.

Unilateral ptosis can be the first symptom related to other causes that are traumatic, myogenic, neurogenic, or mechanical in nature.

Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair

Investigators searched PubMed over the past 2 decades for clinical trials on eyelid ptosis using the terms blepharoptosis or upper eyelid ptosis or eyelid ptosis” and the filters “randomized controlled trial (RCT), clinical trial, and humans.”

Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.

A study suggests that for the general population, evaluation for blepharoptosis should be done at 66 years of age, or at 63 and 70 years for males and females, separately.

Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.

Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.